Changes in treatment landscape of relapsed or refractory multiple myeloma and their association with mortality: Insights from German claims database

OBJECTIVES: Emerging treatments for relapsed or refractory multiple myeloma (rrMM) have led to increasing options for many patients. This study aimed to assess changes in utilization of these options in Germany with a focus on modern triplet regimens including new agents, such as carfilzomib, ixazom...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheid, Christof, Blau, Igor W., Sellner, Leopold, Ratsch, Boris A., Basic, Edin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894176/
https://www.ncbi.nlm.nih.gov/pubmed/32989806
http://dx.doi.org/10.1111/ejh.13523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894176/
https://www.ncbi.nlm.nih.gov/pubmed/32989806
http://dx.doi.org/10.1111/ejh.13523

Ejemplares similares